
April 9, 2025
Contract Manufacturing in Biopharma Evolving Beyond COVID-19
The COVID-19 pandemic catalyzed changes to the biopharma manufacturing landscape, with agility, innovation, and resilience becoming necessary prerequisites. And digital transformation, single-use technologies, and strategic partnerships were driving contract manufacturing that soared. Demand is rebounding, but regulatory changes and automation are reshaping the industry. Welcome to the future, where the nature of demand is shifting,…